Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice

Metabolism: Clinical and Experimental

Volumn 47, Issue 12, 1998, Pages 1477-1480

  Piercy, Valerie ^a   Nigel Toseland, C D ^a   Turner, Nicholas C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; FEMALE; GLUCOSE HOMEOSTASIS; GLYCATION; HUMAN; INSULIN BLOOD LEVEL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031700779     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90073-7     Document Type: Article

References (21)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
3. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
4. Bucala R, Cerami A, Vlassara H: Advanced glycosylation end products in diabetic complications. Diabetes Rev 3:258-268, 1995
5. Unger RH, Grundy S: Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes. Diabetologia 28:119-121, 1985
6. Matsuoka T, Kajimoto Y, Watada H, et al: Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99:144-150, 1997
7. Purrelo F, Vetri M, Gatta C, et al: Effects of high glucose on insulin secretion by isolated rat islets and purified B-cells and possible role of glycosylation. Diabetes 38:1417-1422, 1989
8. Tariji Y, Moller C, Grill V: Long-term effects of aminoguanidine on insulin release and biosynthesis: Evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology 138:273-280, 1997
9. Berglund O, Frankel BJ, Hellamn B: Development of the insulin secretory defect in genetically diabetic (db/db) mouse. Acta Endocrinol (Copenh) 87:543-551, 1980
10. Hummel KP, Dickie MM, Coleman DL: Diabetes, a new mutation in the mouse. Science 153:1127-1128, 1966
11. Robertson RP, Zhang HJ, Pyzdrowski KL, et al: Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320-325, 1992
12. Abdel-Wahab YHA, O'Harte FPM, Ratcliff H, et al: Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45:1489-1496, 1996
13. Brownlee M, Vlassara H, Kooney A, et al: Aminoguanidine prevents diabetes induced arterial wall protein cross linking. Science 232:1629-1632, 1986
14. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26-29, 1992
15. Hirsch J, Barnes CL, Feather MS: X-ray structures of a 3-amino-5- and a 3-amino-6-substituted triazine, produced as a result of a reaction of 3-deoxy-D-erythro-hexos-2-ulose (3-deoxyglucosone) with aminoguanidine. J Carbohydr Chem 11:891-901, 1992
16. Yamanda H, Miyata S, Igaki N, et al: Increase in 3-deoxyglucosone levels in diabetic rat plasma. J Biol Chem 269:20275-20280, 1994
17. Morris TH: Antibiotic therapeutics in laboratory animals. Lab Anim 29:16-36, 1995
18. Mordenti J: Man versus beast: Pharmacokinetic scaling in mammals. J Pharm Sci 75:1028-1040, 1986
19. Coleman DL: Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148, 1978
20. Corbett JA, Tilton RG, Chang K, et al: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992
21. Unger H: How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 7:276-282, 1997